Incidence and Risk Factors Related to SARS-CoV-2 Infection, Reinfection, and Seroconversion: Analysis of a Healthcare Workers Cohort from a University Hospital in Colombia

Overview

Journal IJID Reg

Specialty Infectious Diseases

Date 2023 Nov 6

PMID 37928802

Authors

Maria A Nieto

Nohemi Caballero

Camila I Remolina

Sergio Moreno

Daniela Vega

Juliana Quintero

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the incidence and factors associated with SARS-CoV-2 infection and seroconversion among healthcare workers (HCWs) during the COVID-19 pandemic in a university hospital in Colombia.

Methods: We analyzed the CoVIDA-Fundación Santa Fe de Bogotá (FSFB) cohort, consisting of 419 HCWs from the FSFB university hospital. The cohort was followed during active surveillance (June 25, 2020, to April 30, 2021) and passive surveillance (May 01, 2021, to March 16, 2022) periods. Incidence rates for SARS-CoV-2 infection, reinfection, and seroconversion were estimated, considering pre- and post-COVID-19 vaccination. Cox proportional-hazards models were used to identify factors related to infection and seroconversion during the active surveillance period.

Results: COVID-19 incidence rate ranged between 16-52 cases per 1000 person-month. SARS-CoV-2 reinfections were rare, ranging between less than one case to 13 cases per 1000 person-month. The seroconversion rates ranged between 52-55 cases per 1000 person-month. High socioeconomic level was a protective factor for SARS-CoV-2 infection, while SARS-CoV-2 infection was the main factor associated with seroconversion.

Conclusion: This study provides insights into the incidence and risk factors of SARS-CoV-2 infection among HCWs in a Colombian university hospital. The findings may offer valuable guidance for reducing virus spread within healthcare settings.

Citing Articles

Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers.

Chivu C, Craciun M, Pitigoi D, Arama V, Luminos M, Jugulete G Vaccines (Basel). 2024; 12(6).

PMID: 38932411 PMC: 11209586. DOI: 10.3390/vaccines12060682.

References

Chen Q, Zhu K, Liu X, Zhuang C, Huang X, Huang Y . The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Emerg Microbes Infect. 2022; 11(1):793-803. PMC: 8920404. DOI: 10.1080/22221751.2022.2046446. View

Hawkins R, Charles E, Mehaffey J . Socio-economic status and COVID-19-related cases and fatalities. Public Health. 2020; 189:129-134. PMC: 7568122. DOI: 10.1016/j.puhe.2020.09.016. View

Russo G, Cassenote A, Oliveira B, Scheffer M . Demographic and professional risk factors of SARS-CoV-2 infections among physicians in low- and middle-income settings: Findings from a representative survey in two Brazilian states. PLOS Glob Public Health. 2023; 2(10):e0000656. PMC: 10021204. DOI: 10.1371/journal.pgph.0000656. View

Muralidar S, Ambi S, Sekaran S, Krishnan U . The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020; 179:85-100. PMC: 7505773. DOI: 10.1016/j.biochi.2020.09.018. View

El-Ghitany E, Ashour A, Farghaly A, Hashish M, Omran E . Predictors of anti-SARS-CoV-2 seropositivity: An Egyptian population-based study. Infect Med (Beijing). 2023; 1(2):113-123. PMC: 9212586. DOI: 10.1016/j.imj.2022.06.003. View

Guarnieri V, Moriondo M, Giovannini M, Lodi L, Ricci S, Pisano L . Surveillance on Healthcare Workers During the First Wave of SARS-CoV-2 Pandemic in Italy: The Experience of a Tertiary Care Pediatric Hospital. Front Public Health. 2021; 9:644702. PMC: 8350057. DOI: 10.3389/fpubh.2021.644702. View

Yahav D, Yelin D, Eckerle I, Eberhardt C, Wang J, Cao B . Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2020; 27(3):315-318. PMC: 7718119. DOI: 10.1016/j.cmi.2020.11.028. View

Sainani K . Introduction to Survival Analysis. PM R. 2016; 8(6):580-5. DOI: 10.1016/j.pmrj.2016.04.003. View

Sirijatuphat R, Leelarasamee A, Horthongkham N . Prevalence and factors associated with COVID-19 among healthcare workers at a university hospital in Thailand. Medicine (Baltimore). 2022; 101(38):e30837. PMC: 9508950. DOI: 10.1097/MD.0000000000030837. View

10.

Chemaitelly H, Ayoub H, Almukdad S, Coyle P, Tang P, Yassine H . Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study. Lancet Microbe. 2022; 3(12):e944-e955. PMC: 9651957. DOI: 10.1016/S2666-5247(22)00287-7. View

11.

Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur V, Gupta P . SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. JAMA Netw Open. 2022; 5(1):e2142210. PMC: 8742193. DOI: 10.1001/jamanetworkopen.2021.42210. View

12.

Wang Q, Guo Y, Iketani S, Nair M, Li Z, Mohri H . Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022; 608(7923):603-608. PMC: 9385487. DOI: 10.1038/s41586-022-05053-w. View

13.

Caballero N, Nieto M, Suarez-Zamora D, Moreno S, Remolina C, Duran D . Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia. IJID Reg. 2022; 3:150-156. PMC: 8942465. DOI: 10.1016/j.ijregi.2022.03.013. View

14.

Nordstrom P, Ballin M, Nordstrom A . Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Lancet Infect Dis. 2022; 22(6):781-790. PMC: 8971363. DOI: 10.1016/S1473-3099(22)00143-8. View

15.

Salazar M, Chavez-Galan L, Castorena-Maldonado A, Mateo-Alonso M, Diaz-Vazquez N, Vega-Martinez A . Low Incidence and Mortality by SARS-CoV-2 Infection Among Healthcare Workers in a Health National Center in Mexico: Successful Establishment of an Occupational Medicine Program. Front Public Health. 2021; 9:651144. PMC: 8076634. DOI: 10.3389/fpubh.2021.651144. View

16.

Malagon-Rojas J, Mercado-Reyes M, Toloza-Perez Y, Parra Barrera E, Palma M, Munoz E . Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities. Occup Environ Med. 2021; 79(6):388-395. PMC: 8577941. DOI: 10.1136/oemed-2021-107487. View

17.

Larese Filon F, Rui F, Ronchese F, De Michieli P, Negro C . Incidence of COVID-19 infection in hospital workers from March 1, 2020 to May 31, 2021 routinely tested, before and after vaccination with BNT162B2. Sci Rep. 2022; 12(1):2533. PMC: 8847551. DOI: 10.1038/s41598-021-04665-y. View

18.

Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L . Immune response in COVID-19: what is next?. Cell Death Differ. 2022; 29(6):1107-1122. PMC: 9110941. DOI: 10.1038/s41418-022-01015-x. View

19.

Dzinamarira T, Murewanhema G, Mhango M, Iradukunda P, Chitungo I, Mashora M . COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022; 19(1). PMC: 8750782. DOI: 10.3390/ijerph19010146. View

20.

Massoudi N, Mohit B . A Case-Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers. J Clin Immunol. 2020; 41(2):324-334. PMC: 7690338. DOI: 10.1007/s10875-020-00925-0. View